That's Right Bitches!
Flora Growth reiterates 2022 revenue view $35M-$45M 07:15 FLGC Would realize projected…
I'm not selling! // take that!
Flora Growth reports 2021 revenue $9M vs. $0.1M in 2020 07:14 FLGC "Fiscal year 2021 was a foundational year for our company as we closed our first full year of revenues. In 2022 we anticipate accelerating revenue growth as we activate our Wholesale and Life Sciences growth pillars, while fueling expansion in our global House of Brands," said Luis Merchan, Chairman and CEO of Flora. "We are proud of the milestones we achieved in 2021, including the completion of key strategic infrastructure projects, the strengthening of our balance sheet and the deployment of our M&A strategy. In 2022, we continue to execute on our plan, highlighted by the acquisition of JustCBD, a leading consumer wellness brand. This acquisition increased Flora's footprint to over half a million consumers and 14,000 retail stores in the United States. The transaction is already proving accretive as Flora's unaudited revenues for April represent our strongest revenue month since inception. The completion of our cultivation and extraction facilities has positioned Flora for success in this rapidly evolving industry, as we satisfied the requirements for the cultivation, transformation and export of up to 43.6 tonnes of THC cannabis flower. And in our Life Sciences pillar, we look forward to potential commercial distribution of pharmaceutical-grade products based on the research of Dr. Annabelle Manalo-Morgan."
TOLD YOU! Nobody listens... especially the market.....
Flora Growth reiterates 2022 revenue view $35M-$45M 07:15 FLGC Would realize projected…
I'm not selling! // take that!
Flora Growth reports 2021 revenue $9M vs. $0.1M in 2020 07:14 FLGC "Fiscal year 2021 was a foundational year for our company as we closed our first full year of revenues. In 2022 we anticipate accelerating revenue growth as we activate our Wholesale and Life Sciences growth pillars, while fueling expansion in our global House of Brands," said Luis Merchan, Chairman and CEO of Flora. "We are proud of the milestones we achieved in 2021, including the completion of key strategic infrastructure projects, the strengthening of our balance sheet and the deployment of our M&A strategy. In 2022, we continue to execute on our plan, highlighted by the acquisition of JustCBD, a leading consumer wellness brand. This acquisition increased Flora's footprint to over half a million consumers and 14,000 retail stores in the United States. The transaction is already proving accretive as Flora's unaudited revenues for April represent our strongest revenue month since inception. The completion of our cultivation and extraction facilities has positioned Flora for success in this rapidly evolving industry, as we satisfied the requirements for the cultivation, transformation and export of up to 43.6 tonnes of THC cannabis flower. And in our Life Sciences pillar, we look forward to potential commercial distribution of pharmaceutical-grade products based on the research of Dr. Annabelle Manalo-Morgan."
TOLD YOU! Nobody listens... especially the market.....